MacroGenics, Inc. vs Regenxbio Inc.
Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.
In short
- Regenxbio Inc. is the larger company by market value: $513 M against $238 M for MacroGenics, Inc., 2.2 times as much (market caps of Oct 13, 2026 for MacroGenics, Inc. and Oct 6, 2026 for Regenxbio Inc.).
- Regenxbio Inc. had more revenue: $170 M against $150 M for MacroGenics, Inc., both in the year to December 2025.
- Both made a net loss: $75 M for MacroGenics, Inc. and $194 M for Regenxbio Inc.
- MacroGenics, Inc. keeps more of each dollar of sales: a net margin of -49.9% against -113.8% for Regenxbio Inc.
- MacroGenics, Inc. employs more people: 427 against 372 at Regenxbio Inc. Each employee brings in about $350,117 of revenue at MacroGenics, Inc. and $458,172 at Regenxbio Inc.
- Regenxbio Inc.'s revenue grew faster in its latest fiscal year: +104.5% against -0.3% for MacroGenics, Inc.
- Both are in the distress zone of the Altman Z-score.
Market value, the same start = 100
From Jan 2020: how each one's value moved, whatever its size.
Revenue by fiscal year
US$ billions, as reported in each year's annual results.
Side by side
| Measure | MacroGenics, Inc. MGNX · #15,602 in the world | Regenxbio Inc. RGNX · #12,404 in the world |
|---|---|---|
| Profile | ||
| Country | 🇺🇸 USA | 🇺🇸 USA |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
| Founded | 2000 | — |
| Size | ||
| Market cap | $238 M | $513 M |
| Revenue | $150 M | $170 M |
| Net income | $-75 M▲ best | $-194 M |
| Employees | 427 | 372 |
| Valuation | ||
| Price to sales | 1.6× | 3.3× |
| Price to book | 4.3× | 5.0× |
| Free cash flow yield | -34.9% | -24.6%▲ best |
| Profitability | ||
| Operating margin | -48.7%▲ best | -94.6% |
| Net margin | -49.9%▲ best | -113.8% |
| Return on equity | -86.9%▲ best | -107.0% |
| Growth | ||
| Revenue growth | -0.3% | 104.5%▲ best |
| Revenue growth, 3 years a year | -0.5% | 14.8%▲ best |
| Cash | ||
| Free cash flow margin | -55.5%▲ best | -74.1% |
| Altman Z-score zone | distress | distress |
| Data as of | Market cap Oct 2026; ratios FY2025 | Market cap Oct 2026; ratios FY2025 |
Questions and answers#
Which is bigger, MacroGenics, Inc. or Regenxbio Inc.?
Regenxbio Inc. is the larger company by market value: $513 M against $238 M for MacroGenics, Inc., 2.2 times as much (market caps of Oct 13, 2026 for MacroGenics, Inc. and Oct 6, 2026 for Regenxbio Inc.).
Which makes more money, MacroGenics, Inc. or Regenxbio Inc.?
Regenxbio Inc. had more revenue: $170 M against $150 M for MacroGenics, Inc., both in the year to December 2025. Both made a net loss: $75 M for MacroGenics, Inc. and $194 M for Regenxbio Inc.
Which is more profitable, MacroGenics, Inc. or Regenxbio Inc.?
MacroGenics, Inc. keeps more of each dollar of sales: a net margin of -49.9% against -113.8% for Regenxbio Inc.
Which has more employees, MacroGenics, Inc. or Regenxbio Inc.?
MacroGenics, Inc. employs more people: 427 against 372 at Regenxbio Inc. Each employee brings in about $350,117 of revenue at MacroGenics, Inc. and $458,172 at Regenxbio Inc.
Which is growing faster, MacroGenics, Inc. or Regenxbio Inc.?
Regenxbio Inc.'s revenue grew faster in its latest fiscal year: +104.5% against -0.3% for MacroGenics, Inc.
Which is financially stronger, MacroGenics, Inc. or Regenxbio Inc.?
Both are in the distress zone of the Altman Z-score.